Results 311 to 320 of about 3,141,404 (351)
Some of the next articles are maybe not open access.
BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors
2007BK virus (BKV), JC virus (JCV) and Simian Virus 40 (SV40) are polyomaviruses, highly homologous at the DNA and protein levels. While the human polyomaviruses BKV and JCV are ubiquitous in humans, SV40 is a simian virus which was introduced in the human population, between 1955 and 1963, by contaminated poliovaccines produced in SV40-infected monkey ...
Barbanti Brodano G +5 more
openaire +2 more sources
Immune recognition of tumor cells in mice infected with Pichinde virus
Cancer Immunology Immunotherapy, 1984Pichinde virus (PV), a member of the Arenaviridae family, protects mice from a lethal inoculation with the sarcoma 180 (S180) tumor cell line. Virus replication, which is required for protection, occurs primarily in the spleen and tumor. During the first 4 days, elevated natural killer (NK) cell activity parallels an increase in serum interferon in PV ...
N, Molomut +4 more
openaire +2 more sources
Murine mammary tumor virus: characterization of infection of nonmurine cells
Journal of Virology, 1976Murine mammary tumor virus (MuMTV) was used to productively infect feline and mink cells. MuMTV "proviral" DNA could be detected in the infected cells by molecular hybridization using radioactive MuMTV complementary DNA as a probe. Kinetic analysis of MuMTV proviral DNA synthesis after infection showed that maximum MuMTV DNA synthesis was achieved by 8
A B, Vaidya +4 more
openaire +2 more sources
Ultrastructure of Tumor Cells in Marek's Disease Virus-Infected Chickens
American Journal of Veterinary Research, 1973SUMMARY Marek's disease (md) visceral tumors from 5½-week-old chickens exposed to the GA isolate of md herpsvirus (mdhv) were examined by electron microscopy determine the fine structure of the lesion. In contrast to the neural lesions of md, which are composed of a mixture of cell types, the visceral tumors contained only one cell type, an immature ...
R L, Doak, J F, Munnell, W L, Ragland
openaire +2 more sources
Modulation of Antigen Processing and Presentation by Persistent Virus Infections and in Tumors
Human Immunology, 1997Cell-mediated immunity is effective against cells harboring active virus replication and is critical for the elimination of ongoing infections, opposing tumor progression, and reducing or preventing the reactivation of persistent viruses and tumor metastasis.
openaire +2 more sources
Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth.
Cancer research, 1981The ubiquitous nononcogenic lactic dehydrogenase RNA virus (LDV) is one of the most common contaminants of transplantable tumors and oncogenic viral preparations. This association of LDV with a large variety of murine tumors and the known effect of LDV infection on immune competence may suggest the existence of a possible etiological relationship ...
Isakov, N, Feldman, M, Segal, S
openaire +1 more source
Progress of SLFN family proteins in tumor and virus infection.
Yi chuan = Hereditas, 2020Schlafen (SLFN) family genes were initially found in humans and rats to regulate cell growth and T cell differentiation, and exist widely in mice, horses, humans and other species and exhibit high homology. Lines of evidence suggest that SLFN proteins play important roles in inhibiting cell proliferation, promoting meiosis, regulating hematopoietic ...
Shu Min, Chen, Ling, Ma, Shan, Cen
openaire +1 more source
Mouse mammary tumor virus infections: viral expression and tumor risk.
Journal of the National Cancer Institute, 1979Concentrations of murine mammary tumor virus (MuMTV) antigen in the milk of individual naturally infected BALB/cfC3H and BALB/c mice given injections of MuMTV were related to their risk of developing a mammary tumor. Two distinct groups of MuMTV-infected mice were identified.
Altrock, B W, Cardiff, R D
openaire +1 more source
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Rebecca L. Siegel +2 more
exaly